The device is now available in the U.S. for the treatment of wide-neck intracranial aneurysms. Aliso Viejo, California-based MicroVention first launched the device in Europe in 2019, selling more than 12,000 units since.

According to a news release, LVIS EVO is the first fully visible coil-assist-intracranial stent available on the U.S. market.

The device features enhanced visualization, optimized opening and precise placement with DFT wire construction and advanced braid design. With enhanced visualization, it also provides wall apposition confirmation, with full visibility of the stent’s entire body under fluoroscopy.